Filament Health, a subsidiary of Rhelion Life Sciences, has shipped its botanical psilocybin drug candidate PEX010 to the University of Calgary for a Phase 2 clinical trial called PsiPTSD. This trial will test psilocybin-assisted therapy for chronic PTSD in survivors of intimate partner violence, led by Dr. Chantel Debert. PEX010 is a standardized, pharmaceutical-grade natural psilocybin product used in over 80 research studies globally. The shipment marks continued progress in developing psilocybin therapies for mental health conditions, with further dosing options planned and ongoing integration of Filament into Rhelion's operations.
Rhelion Life Sciences' subsidiary Filament Health's shipment of PEX010 for a Phase 2 PTSD trial provides context for health sector activity. For readers following health stocks, here is Pluang's market snapshot as of Sep 29, 2026 18:14 WIB: out of 100 priced US health-sector stocks, 44 rose and 49 fell. Notable movers include HRTX at USD 0.28 with a 4.04% decline and 60% sell order activity, CTXR at USD 0.57 up 3.28% with 100% buy orders, and AMPH at USD 28.08 up 2.52% with 99% buy orders. Typical hold times range from 16 to 35 days on Pluang.
01 Quantum Inc. announced that the US Patent Office has granted them a patent for their "Secure AI Operations" technology, which uses computation-preserving cryptography to keep user data encrypted during AI processing. This innovation protects sensi...
The cryptocurrency token PUMP rose 4.03% within one hour to $0.005238 on September 29, extending its 24-hour gain to 4.32%. This surge pushed its market capitalization to approximately $2.34 billion, ranking it 48th among crypto assets by market cap....
iQSTEL has developed a global telecommunications platform offering international voice and data termination services. Despite rapid growth to a revenue run rate exceeding $0.5 billion through acquisitions and organic expansion, the company has yet to...
Valour Inc. and Valour Digital Securities Limited, subsidiaries of DeFi Technologies Inc., launched a new exchange-traded product (ETP) denominated in Swedish krona and tied to the cryptocurrency Zcash on September 29. This product allows investors t...
Atlas Salt announced successful beneficiation test results on nepheline syenite from its Black Bay property, reducing iron oxide impurities to 0.01-0.03%, well below industry limits, using simple magnetic separation. This high-purity product meets sp...
